The introduction of nicotinamide being a nicotine substitute in e-cigarette and smokeless products and solutions represents an important regulatory problem with the FDA. Nicotinamide does not have nicotinic receptor agonist action and is thought to act as a sedative at higher dosages6. The promises made by Nicotine River, ECBlend, as well as other